Answers are grounded in this paper and cite their sources.
MVI has widely been considered as an important prognostic biomarker of hepatocellular carcinoma (HCC). This study aims to non-invasively identify MVI in HCC with susceptibility-weighted-imaging (SWI)-derived radiomics. The results indicated that SWI-derived radiomics are valuable for noninvasively and accurately identifying the MVI status of HCC. Furthermore, the integration of radiomics and clinical factors yielded a predictive nomogram with satisfying diagnostic performance and potential clinical benefits.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: